Table 2.
Sequence Name | P-value | FDR | Fold Change | Regulation | Strand | Relationship | CNV 1 | CNV 2 | CNV 3 | Control 1 | Control 2 | Control 3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
AK036888 | 0.000171 | 0.150561 | 13.378940 | up | - | intergenic | 6.585418 | 6.480785 | 6.071276 | 3.077727 | 2.512265 | 2.321811 |
uc007pgi.1 | 0.014847 | 0.390976 | 9.578848 | up | - | intergenic | 5.211190 | 7.107776 | 4.430212 | 2.325983 | 2.321827 | 2.321811 |
AK078702 | 0.000536 | 0.150561 | 7.117427 | up | - | intergenic | 6.359641 | 6.132188 | 6.161450 | 3.862077 | 3.371296 | 2.925838 |
AK035526 | 0.005083 | 0.298875 | 6.657825 | up | + | natural antisense | 5.724644 | 7.089529 | 7.076339 | 4.231499 | 3.878298 | 3.575563 |
uc009ewo.1 | 0.000984 | 0.182037 | 5.719433 | up | - | intron sense-overlapping | 8.163315 | 7.829017 | 7.371524 | 5.300458 | 5.566779 | 4.949003 |
AK036625 | 0.005126 | 0.298875 | 5.353162 | up | - | intergenic | 5.726749 | 5.680111 | 5.143081 | 2.325983 | 3.345529 | 3.617254 |
ENSMUST00000148005 | 0.001561 | 0.218932 | 5.264145 | up | + | exon sense-overlapping | 6.509248 | 6.302205 | 5.601678 | 3.998450 | 3.479648 | 3.746437 |
ENSMUST00000153541 | 0.000164 | 0.150561 | 4.957192 | up | + | exon sense-overlapping | 11.456490 | 11.349358 | 10.999685 | 9.005207 | 9.098501 | 8.773256 |
AK008836 | 0.004393 | 0.293747 | 4.888444 | up | - | intronic antisense | 7.371524 | 6.772026 | 6.602773 | 4.573347 | 5.202004 | 4.102845 |
ENSMUST00000146254 | 0.000028 | 0.106609 | 4.640225 | up | - | exon sense-overlapping | 7.526886 | 7.218386 | 7.363228 | 5.129217 | 5.254380 | 5.082319 |
NR_026843 | 0.001265 | 0.203615 | 4.591574 | up | - | natural antisense | 6.264922 | 6.398417 | 5.991045 | 4.478630 | 3.930072 | 3.648715 |
ENSMUST00000122340 | 0.001105 | 0.191468 | 4.442445 | up | - | intronic antisense | 8.984519 | 8.526921 | 8.527271 | 6.376287 | 6.936308 | 6.272055 |
AK082144 | 0.000016 | 0.106609 | 4.424734 | up | - | intergenic | 6.554079 | 6.639836 | 6.746826 | 4.380675 | 4.513834 | 4.609461 |
AK048117 | 0.001609 | 0.221747 | 4.382340 | up | - | intergenic | 9.343423 | 9.431755 | 9.431267 | 7.627238 | 6.720520 | 7.463583 |
ENSMUST00000143423 | 0.000941 | 0.181475 | 4.307678 | up | + | exon sense-overlapping | 4.561347 | 5.009892 | 4.564078 | 2.963872 | 2.321827 | 2.528887 |
AK148935 | 0.000638 | 0.156222 | 4.263167 | up | - | intergenic | 8.259856 | 8.525405 | 8.333067 | 6.682964 | 6.086507 | 6.073080 |
AK047865 | 0.001065 | 0.191468 | 4.256438 | up | - | intergenic | 9.039629 | 8.963352 | 9.098866 | 7.275191 | 6.469285 | 7.088430 |
ENSMUST00000141975 | 0.000283 | 0.150561 | 4.232972 | up | - | exon sense-overlapping | 6.736901 | 6.384502 | 6.153523 | 4.416513 | 4.338800 | 4.274602 |
uc029sdr.1 | 0.000052 | 0.120829 | 4.185189 | up | + | intergenic | 10.768113 | 10.641598 | 10.589025 | 8.507404 | 8.798939 | 8.496515 |
NR_045384 | 0.010196 | 0.362008 | 4.172997 | up | + | intergenic | 5.724329 | 5.884554 | 5.893274 | 4.532355 | 3.801238 | 2.985313 |
P-values were calculated using unpaired t-test. FDR: false discovery rate. Fold change: the absolute ratio (no log scale) of average normalized intensities between CNV group and control group. CNV 1 to 3 and Control 1 to 3: each sample's normalized intensity (log2 scale). Hereinafter the same.